These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 4936148)
1. Comparative tolerability of drug therapies for hypercalcaemia of malignancy. Zojer N; Keck AV; Pecherstorfer M Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053 [TBL] [Abstract][Full Text] [Related]
2. Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Patel S; Lyons AR; Hosking DJ Drugs; 1993 Oct; 46(4):594-617. PubMed ID: 7506648 [TBL] [Abstract][Full Text] [Related]
3. Management of severe hypercalcaemia. Br Med J; 1980 Jan; 280(6209):204-5. PubMed ID: 7427079 [No Abstract] [Full Text] [Related]
4. Treatment of hypercalcaemia associated with malignancy. Wilkinson R Br Med J (Clin Res Ed); 1984 Mar; 288(6420):812-3. PubMed ID: 6423093 [No Abstract] [Full Text] [Related]
5. Disequilibrium hypercalcaemia. Hosking DJ Br Med J (Clin Res Ed); 1983 Jan; 286(6362):326-7. PubMed ID: 6402083 [No Abstract] [Full Text] [Related]
6. Drug interferences with clinical laboratory tests. Sher PP Drugs; 1982 Jul; 24(1):24-63. PubMed ID: 6179732 [TBL] [Abstract][Full Text] [Related]
8. Drugs for disorders of bone: pharmacological and clinical considerations. Mundy GR; Raisz LG Drugs; 1974; 8(4):250-89. PubMed ID: 4281383 [No Abstract] [Full Text] [Related]
9. Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy. Hosking DJ; Heller SR Eur J Clin Pharmacol; 1986; 31(1):27-31. PubMed ID: 3780823 [TBL] [Abstract][Full Text] [Related]
10. Renal handling of calcium and sodium in metastatic and non-metastatic malignancy. Heller SR; Hosking DJ Br Med J (Clin Res Ed); 1986 Mar; 292(6520):583-6. PubMed ID: 3081177 [TBL] [Abstract][Full Text] [Related]
11. [Hypo and hypercalcemia as an emergency]. Haas HG; Dambacher MA; Guncaga J Klin Wochenschr; 1975 May; 53(10):451-9. PubMed ID: 1104994 [TBL] [Abstract][Full Text] [Related]
12. The pathophysiology and clinical aspects of hypercalcemic disorders. Lee DB; Zawada ET; Kleeman CR West J Med; 1978 Oct; 129(4):278-320. PubMed ID: 362722 [TBL] [Abstract][Full Text] [Related]
13. The role of antitumor antibiotics in current oncologic practice. Davis HL; von Hoff DD; Henney JE; Rozencweig M Cancer Chemother Pharmacol; 1978; 1(2):83-90. PubMed ID: 219963 [TBL] [Abstract][Full Text] [Related]
14. Hypocalcaemic response to streptomycin in malignant hypercalcaemia. Roediger WE; Ludwin D; Hinder RA Postgrad Med J; 1975 Jun; 51(596):399-401. PubMed ID: 175360 [TBL] [Abstract][Full Text] [Related]
15. New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin. Slayton RE; Shnider BI; Elias E; Horton J; Perlia CP Clin Pharmacol Ther; 1971; 12(5):833-7. PubMed ID: 4936148 [No Abstract] [Full Text] [Related]
16. Mithramycin treatment of hypercalcemia. Perlia CP; Gubisch NJ; Wolter J; Edelberg D; Dederick MM; Taylor SG Cancer; 1970 Feb; 25(2):389-94. PubMed ID: 5413510 [No Abstract] [Full Text] [Related]